Ibrahim Mohammed, Khan Aleem-A, Tiwari Santosh-K, Habeeb Mohammed-Aejaz, Khaja M-N, Habibullah C-M
Centre for Liver Research and Diagnostics, Deccan college of Medical Sciences and Allied Hospitals, Kanchanbagh, Hyderabad 500064, India.
World J Gastroenterol. 2006 Nov 28;12(44):7136-42. doi: 10.3748/wjg.v12.i44.7136.
to evaluate the antibacterial activity of Sapindus mukorossi (S. mukorossi) and Rheum emodi (R. emodi).
Powders of S. mukorossi and R. emodi were extracted successively with petroleum ether, benzene, chloroform and ethanol and were concentrated in vacuum. The disk diffusion method was used for in vitro studies and in vivo studies were performed on male Wister rats. Thirty resistant clinical isolates of H pylori, as determined by their antibiotic sensitivity patterns by E-test, along with two Gram +ve (S. aureus, B. subtilis) and two Gram -ve (E. coli, P. vugaris) organisms were screened for their susceptibility patterns against these extracts.
In our screening, all 30 resistant isolates and the other four organisms (two Gram +ve S. aureus, B. subtilis and two Gram -ve, E. coli, P. vugaris) were sensitive to the test compounds. It was found that ethanol and chloroform extracts of S. mukorossi and ethanol and benzene extracts of R. emodi inhibited H pylori at very low concentrations. In the in vitro study, the isolates showed a considerable zone of inhibition at very low concentrations (10 mug/mL) for both the extracts. In the in vivo study, the H pylori infection was cleared with minimal doses of extracts of S. mukorossi (2.5 mg/mL) and R. emodi (3.0 mg/mL) given orally for seven days.
We can conclude from this study that the extracts of S. mukorossi and R. emodi inhibited the growth of pylori in vitro and, in in vivo studies, the H pylori infection cleared within seven days at very low concentrations. We also found that H pylori did not acquire resistance against these herbal extracts even after 10 consecutive passages.
评估无患子和喜马拉雅大黄的抗菌活性。
无患子和喜马拉雅大黄粉末依次用石油醚、苯、氯仿和乙醇提取,然后真空浓缩。采用纸片扩散法进行体外研究,并在雄性Wistar大鼠上进行体内研究。通过E试验确定30株对多种抗生素耐药的临床幽门螺杆菌分离株,以及两种革兰氏阳性菌(金黄色葡萄球菌、枯草芽孢杆菌)和两种革兰氏阴性菌(大肠杆菌、普通变形杆菌),检测它们对这些提取物的敏感性。
在我们的筛选中,所有30株耐药分离株以及其他四种菌(两种革兰氏阳性菌金黄色葡萄球菌、枯草芽孢杆菌和两种革兰氏阴性菌大肠杆菌、普通变形杆菌)对受试化合物敏感。发现无患子的乙醇和氯仿提取物以及喜马拉雅大黄的乙醇和苯提取物在极低浓度下就能抑制幽门螺杆菌。在体外研究中,两种提取物在极低浓度(10微克/毫升)下就能使分离株出现相当大的抑菌圈。在体内研究中,口服极低剂量的无患子提取物(2.5毫克/毫升)和喜马拉雅大黄提取物(3.0毫克/毫升)7天,幽门螺杆菌感染就被清除。
从本研究中我们可以得出结论,无患子和喜马拉雅大黄提取物在体外能抑制幽门螺杆菌生长,在体内研究中,极低浓度下7天内就能清除幽门螺杆菌感染。我们还发现,即使连续传代10次,幽门螺杆菌也未对这些草药提取物产生耐药性。